Fernando
Martínez Regueira
Consultor Médico
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublicacións en colaboración con investigadores/as de University of Texas MD Anderson Cancer Center (1)
2010
-
Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer
Cancer Chemotherapy and Pharmacology, Vol. 65, Núm. 3, pp. 457-465